Polyrizon Ltd (PLRZ)

• Market cap: $15M
• 1 day: -6.31%
• 5 days: -2.44%
• 1 month: 79.33%
• 3 months: 120.18%
• 6 months: 65.52%
• Year to date: 12.94%
• 1 year: -99.3%
• 5 years: -99.38%
• 10 years: -99.38%
• Sector: Healthcare
• Industry: Biotechnology

About: Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.